162 related articles for article (PubMed ID: 26258493)
1. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.
Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J
Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of glutaminase 2 in human liver and colon cancers.
Zhang J; Wang C; Chen M; Cao J; Zhong Y; Chen L; Shen HM; Xia D
BMC Cancer; 2013 Dec; 13():601. PubMed ID: 24330717
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma.
Majewska E; Rola R; Barczewska M; Marquez J; Albrecht J; Szeliga M
J Physiol Pharmacol; 2017 Apr; 68(2):209-214. PubMed ID: 28614770
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.
Szeliga M; Albrecht J
Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
6. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.
Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ
Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339
[TBL] [Abstract][Full Text] [Related]
7. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.
Liu F; Cox CD; Chowdhury R; Dovek L; Nguyen H; Li T; Li S; Ozer B; Chou A; Nguyen N; Wei B; Antonios J; Soto H; Kornblum H; Liau L; Prins R; Nghiemphu PL; Yong W; Cloughesy T; Lai A
J Neurooncol; 2019 May; 142(3):423-434. PubMed ID: 30838489
[TBL] [Abstract][Full Text] [Related]
8. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
[TBL] [Abstract][Full Text] [Related]
9. TP53 promoter methylation in human gliomas.
Amatya VJ; Naumann U; Weller M; Ohgaki H
Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
Ghasemi A; Fallah S; Ansari M
Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
12. TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status.
Jesionek-Kupnicka D; Szybka M; Malachowska B; Fendler W; Potemski P; Piaskowski S; Jaskolski D; Papierz W; Skowronski W; Och W; Kordek R; Zawlik I
DNA Cell Biol; 2014 Apr; 33(4):217-26. PubMed ID: 24506545
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas.
Waha A; Felsberg J; Hartmann W; Hammes J; von dem Knesebeck A; Endl E; Pietsch T; Waha A
Int J Cancer; 2012 Aug; 131(3):612-22. PubMed ID: 21901745
[TBL] [Abstract][Full Text] [Related]
14. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
15. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
[TBL] [Abstract][Full Text] [Related]
16. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.
Malley DS; Hamoudi RA; Kocialkowski S; Pearson DM; Collins VP; Ichimura K
Acta Neuropathol; 2011 May; 121(5):651-61. PubMed ID: 21287394
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines.
Kadowaki M; Yoshioka H; Kamitani H; Watanabe T; Wade PA; Eling TE
Int J Cancer; 2012 Jan; 130(2):267-77. PubMed ID: 21437897
[TBL] [Abstract][Full Text] [Related]
19. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation.
Pogribny IP; James SJ
Cancer Lett; 2002 Feb; 176(2):169-74. PubMed ID: 11804744
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.
Waha A; Felsberg J; Hartmann W; von dem Knesebeck A; Mikeska T; Joos S; Wolter M; Koch A; Yan PS; Endl E; Wiestler OD; Reifenberger G; Pietsch T; Waha A
Cancer Res; 2010 Feb; 70(4):1689-99. PubMed ID: 20124482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]